A standardised FACS assay based on native, receptor transfected cells for the clinical diagnosis and monitoring of β1-adrenergic receptor autoantibodies in human heart disease

Clinical Chemistry and Laboratory Medicine

Volumn 54, Issue 4, 2016, Pages 683-691

  Bornholz, Beatrice ^a   Benninghaus, Thomas ^a   Reinke, Yvonne ^b,c   Felix, Stephan B ^b,c   Roggenbuck, Dirk ^d,e   Jahns Boivin, Valérie ^f   Jahns, Roland ^g   Boege, Fritz ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^d BRANDENBURG UNIVERSITY OF TECHNOLOGY   (Germany)

^e GA GENERIC ASSAYS GMBH   (Germany)

^f UNIVERSITY OF WÜRZBURG   (Germany)

^g UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

autoantibodies; companion assay; diagnostic testing; dilated cardiomyopathy; targeted therapy; 1 adrenergic receptors

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR AUTOANTIBODY; BRAIN NATRIURETIC PEPTIDE; IMMUNOGLOBULIN G; RECEPTOR ANTIBODY; TROPONIN I; UNCLASSIFIED DRUG; AUTOANTIBODY; BETA 1 ADRENERGIC RECEPTOR;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CELL SURFACE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; GOOD LABORATORY PRACTICE; HEART DISEASE; HEART FAILURE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; BLOOD; CARDIOMYOPATHY, DILATED; GENETICS; IMMUNOLOGY; MIDDLE AGED; STANDARDS;

ADULT; AGED; AUTOANTIBODIES; CARDIOMYOPATHY, DILATED; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ADRENERGIC, BETA-1; SENSITIVITY AND SPECIFICITY;

EID: 84961820772     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2015-0603     Document Type: Article

References (32)

1. Bornholz B, Roggenbuck D, Jahns R, Boege F. Diagnostic and therapeutic aspects of beta-adrenergic receptor autoantibodies in human heart disease. Autoimmun Rev 2014;13:954-62.
2. Wallukat G, Schimke I. Agonistic autoantibodies directed against g-protein-coupled receptors and their relationship to cardiovascular diseases. Sem Immunopathol 2014;36:351-63.
3. Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, et al. Direct evidence for a beta(1)-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 2004;113:1419-29.
4. Jahns R, Boivin V, Lohse MJ. Beta(1)-adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy. Trends Cardiovasc Med 2006;16:20-4.
5. Stork S, Boivin V, Horf R, Hein L, Lohse MJ, Angermann CE, et al. Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Am Heart J 2006;152:697-704.
6. Dandel M, Wallukat G, Potapov E, Hetzer R. Role of beta(1)- adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy. Immunobiol 2012;2017:511-20.
7. Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F. Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 1999;99:649-54.
8. Nikolaev VO, Boivin V, Stork S, Angermann CE, Ertl G, Lohse MJ, et al. A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure. J Am Coll Cardiol 2007;50:423-31.
9. Iwata M, Yoshikawa T, Baba A, Anzai T, Mitamura H, Ogawa S. Autoantibodies against the second extracellular loop of beta(1)- adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2001;37:418-24.
10. Jahns R, Boivin V, Siegmund C, Boege F, Lohse MJ, Inselmann G. Activating beta-1-adrenoceptor antibodies are not associated with cardiomyopathies secondary to valvular or hypertensive heart disease. J Am Coll Cardiol 1999;34:1545-51.
11. Liu HR, Zhao RR, Zhi JM, Wu BW, Fu ML. Screening of serum autoantibodies to cardiac beta1-adrenoceptors and m2-muscarinic acetylcholine receptors in 408 healthy subjects of varying ages. Autoimmunity 1999;29:43-51.
12. Bornholz B, Weidtkamp-Peters S, Schmitmeier S, Seidel CA, Herda LR, Felix SB, et al. Impact of human autoantibodies on beta1-adrenergic receptor conformation, activity, and internalization. Cardiovasc Res 2013;97:472-80.
13. Wallukat G, Nisson E. Anti beta(1)-adrenoceptor autoantibodies analyzed in spontaneously beating neonatal rat heart myocyte cultures - comparison of methods. Dev Biol 2001;37:175-6.
14. Patel PA, Hernandez AF. Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy. Eur J Heart Fail 2013;15:724-9.
15. Dandel M, Wallukat G, Englert A, Hetzer R. Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension. Atherosclerosis Suppl 2013;14:203-11.
16. Felix SB, Staudt A, Landsberger M, Grosse Y, Stangl V, Spielhagen T, et al. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J Am Coll Cardiol 2002;39:646-52.
17. Haberland A, Wallukat G, Dahmen C, Kage A, Schimke I. Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies. Circ Res 2011;109:986-92.
18. Munch G, Boivin-Jahns V, Holthoff HP, Adler K, Lappo M, Truol S, et al. Administration of the cyclic peptide cor-1 in humans (phase I study): Ex vivo measurements of anti-beta1-adrenergic receptor antibody neutralization and of immune parameters. Eur J Heart Fail 2012;14:1230-9.
19. Haberland A, Wallukat G, Berg S, Schulz AM, Freyse EJ, Vetter R, et al. Neutralization of pathogenic beta1-receptor autoantibodies by aptamers in vivo: the first successful proof of principle in spontaneously hypertensive rats. Mol Cell Biol 2014;393:177-80.
20. Boivin V, Beyersdorf N, Palm D, Nikolaev VO, Schlipp A, Muller J, et al. Novel receptor-derived cyclopeptides to treat heart failure caused by anti-beta1-adrenoceptor antibodies in a human-analogous rat model. PLoS One 2015;10:e0117589.
21. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, et al. High-resolution crystal structure of an engineered human beta2-adrenergic g protein-coupled receptor. Science 2007;318:1258-65.
22. Jahns R, Boivin V, Krapf T, Wallukat G, Boege F, Lohse MJ. Modulation of beta(1)-adrenoceptor activity by domain-specific antibodies and-heart failure-associated autoantibodies. J Am Coll Cardiol 2000;36:1280-7.
23. Jahns R, Boege F. Questionable validity of petide-based elisa strategies in the diagnostics of cadrdiopathogenic autoantibodies that activate g-protein-coupled receptors. Cardiology 2015;131:149-50.
24. Jahns R, Schlipp A, Boivin V, Lohse MJ. Targeting receptor antibodies in immune cardiomyopathy. Semin Thromb Hemost 2010;36:212-8.
25. Hohensinner PJ, Goronzy JJ, Weyand CM. Telomere dysfunction, autoimmunity and aging. Aging Dis 2011;2:524-37.
26. Pei J, Li N, Chen J, Li X, Zhang Y, Wang Z, et al. The predictive values of beta1-adrenergic and m2 muscarinic receptor autoantibodies for sudden cardiac death in patients with chronic heart failure. Eur J Heart Fail 2012;14:887-94.
27. Holthoff HP, Zeibig S, Boivin V, Bauer J, Lohse MJ, Kaab S, et al. Detection of anti beta1-ar auto-antibodies in heart failure by a cell-based competition elisa. Circ Res 2012;111:675-84.
28. Christ T, Adolph E, Schindelhauer S, Wettwer E, Dobrev D, Wallukat G, et al. Effects of immunoglobulin g from patients with dilated cardiomyopathy on rat cardiomyocytes. Basic Clin Pharmacol Toxicol 2005;96:445-52.
29. Eckerle LG, Felix SB, Herda LR. Measurement of antibody effects on cellular function of isolated cardiomyocytes. J Vis Exp 2013;e4237.
30. Lytton SD, Kahaly GJ. Bioassays for tsh-receptor autoantibodies: an update. Autoimmun Rev 2010;10:116-22.
31. Roggenbuck D, Hiemann R, Bogdanos D, Reinhold D, Conrad K. Standardization of automated interpretation of immunofluorescence tests. Clin Chim Acta 2013;421:168-9.
32. Deubner N, Berliner D, Schlipp A, Gelbrich G, Caforio AL, Felix SB, et al. Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the etiology, titre-course, and survival (etics) study. Eur J Heart Fail 2010;12:753-62.